ConductScience.org, home

Paper28299466

Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein.

Kitagawa K and 9 others. Cancer Immunol Immunother, 2017. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein. Papers, record 28299466. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28299466

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2024-04-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kitagawa KKoichi
2Oda TTsugumi
3Saito HHiroki
4Araki AAyame
5Gonoi RReina
6Shigemura KKatsumi
7Hashii YYoshiko
8Katayama TTakane
9Fujisawa MMasato
10Shirakawa TToshirohttps://orcid.org/0000-0003-3925-8730

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BifidobacteriumMajor topic
Cancer VaccinesMajor topic
ImmunotherapyMajor topic
Mouth NeoplasmsMajor topic
WT1 ProteinsMajor topic
Animals
Female
Mice
Mice, Inbred C57BL
Survival Rate
T-Lymphocytes, Cytotoxic

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118502632WT1 peptide vaccine for the treatment of cancer.Curr Opin Immunol2008https://conductscience.org/library/papers/18502632PubMed
220582983WT1 peptide immunotherapy for cancer in children and young adults.Pediatr Blood Cancer2010https://conductscience.org/library/papers/20582983PubMed
319389880A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.Blood2009https://conductscience.org/library/papers/19389880PubMed
420071048Distinct Bifidobacterium strains drive different immune responses in vitro.Int J Food Microbiol2010https://conductscience.org/library/papers/20071048PubMed
518354418Adoptive cell transfer: a clinical path to effective cancer immunotherapy.Nat Rev Cancer2008https://conductscience.org/library/papers/18354418PubMed
621792083Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma.Pancreas2012https://conductscience.org/library/papers/21792083PubMed
725904595Cancer vaccines.BMJ2015https://conductscience.org/library/papers/25904595PubMed
824657718Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice.Vaccine2014https://conductscience.org/library/papers/24657718PubMed
926541606Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.Science2015https://conductscience.org/library/papers/26541606PubMed
1025914340Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.Biotechnol J2015https://conductscience.org/library/papers/25914340PubMed
1119351755Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.Clin Cancer Res2009https://conductscience.org/library/papers/19351755PubMed
1225258102Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients.Vaccine2014https://conductscience.org/library/papers/25258102PubMed
1310942395Immunity to WT1 in the animal model and in patients with acute myeloid leukemia.Blood2000https://conductscience.org/library/papers/10942395PubMed
1420709009Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model.Vaccine2010https://conductscience.org/library/papers/20709009PubMed
1520170766Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7.Vaccine2010https://conductscience.org/library/papers/20170766PubMed
1612772509Enhancing immunogenicity by CpG DNA.Curr Opin Mol Ther2003https://conductscience.org/library/papers/12772509PubMed
1723801305Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells.Mucosal Immunol2014https://conductscience.org/library/papers/23801305PubMed
1816614236TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility.Oncologist2006https://conductscience.org/library/papers/16614236PubMed
197949179WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.Blood1994https://conductscience.org/library/papers/7949179PubMed
2018524406Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.Int J Food Microbiol2008https://conductscience.org/library/papers/18524406PubMed

See all 39 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
41135875Programmable microbial therapeutics: advances in engineered bacteria for targeted in vivo delivery and precision medicine.J Adv Res2026https://conductscience.org/library/papers/41135875PubMed
40893667Blades and barriers: Oral vaccines for conquering cancers and warding off infectious diseases.Acta Pharm Sin B2025https://conductscience.org/library/papers/40893667PubMed
40299687Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer.Biomedicines2025https://conductscience.org/library/papers/40299687PubMed
40296128The human microbiome: redefining cancer pathogenesis and therapy.Cancer Cell Int2025https://conductscience.org/library/papers/40296128PubMed
40282924Gut Microbiota-Based Immunotherapy: Engineered Escherichia coli Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer.Medicina (Kaunas)2025https://conductscience.org/library/papers/40282924PubMed
39905323
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial.
BMC Cancer2025https://conductscience.org/library/papers/39905323PubMed
39594765Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy.Cancers (Basel)2024https://conductscience.org/library/papers/39594765PubMed
38472176Promising dawn in tumor microenvironment therapy: engineering oral bacteria.Int J Oral Sci2024https://conductscience.org/library/papers/38472176PubMed
37600773Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies.Front Immunol2023https://conductscience.org/library/papers/37600773PubMed
37340017An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model.Sci Rep2023https://conductscience.org/library/papers/37340017PubMed
36803483Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia.BMC Cancer2023https://conductscience.org/library/papers/36803483PubMed
36324027Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review.Mol Biol Rep2023https://conductscience.org/library/papers/36324027PubMed
35522104Bacteria in cancer therapy: A new generation of weapons.Cancer Med2022https://conductscience.org/library/papers/35522104PubMed
34589578An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model.Mol Ther Oncolytics2021https://conductscience.org/library/papers/34589578PubMed
32564632Microbiome as a Target for Cancer Therapy.Integr Cancer Ther2020https://conductscience.org/library/papers/32564632PubMed
31500086Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy.Cancers (Basel)2019https://conductscience.org/library/papers/31500086PubMed
30949803Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy.Curr Microbiol2019https://conductscience.org/library/papers/30949803PubMed
29048978Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine.Hum Vaccin Immunother2018https://conductscience.org/library/papers/29048978PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28299466

GET https://conductscience.org/api/papers/v1/28299466/references?page=2